NHI white logo

Robert J. Cubeddu, MD

The Brynne and Bob Coletti Endowed Chair for the
President of the NCH Heart Institute
Section Head,
Structural and Valvular Heart Disease
Director, Cardiovascular Research

“Our goal is to become a top program
in the country for cardiac care.”
NHI white logo

Robert J. Cubeddu, MD

The Brynne and Bob Coletti Endowed Chair for the President of the NCH Heart Institute
Section Head, Structural and Valvular Heart Disease
Director, Cardiovascular Research

“Our goal is to become a top program in the country for cardiac care.”

ABOUT DR. CUBEDDU

Loading ...

Robert J. Cubeddu, MD joined the NCH organization as the President of the NCH Heart Institute in June 2021.

Dr. Cubeddu is a world-renowned cardiologist and comes to NCH from Cleveland Clinic Florida, where he served as Chairman of Cardiovascular Medicine and Regional Director of Structural Heart Disease. Dr. Cubeddu brings a reputation of excellence and exemplary quality with extraordinary patient outcomes. Dr. Cubeddu lives in Naples with his wife, Alexandria, and their three children.

Meet Dr. Cubeddu

MEDICAL EDUCATION

Structural and Adult Congenital Heart Disease Interventions
Massachusetts General Hospital, Harvard Medical School, Boston, MA

Interventional Cardiology
Massachusetts General Hospital, Harvard Medical School, Boston, MA

Cardiovascular Diseases
Mount Sinai Medical Center, Miami, FL

Internal Medicine Chief Resident
Mount Sinai Medical Center, Miami, FL

Internal Medicine Residency
Mount Sinai Medical Center, Miami, FL

Medical Doctorate
Central University of Venezuela, School of Medicine “Luis Razetti,” Caracas, Venezuela

BOARD CERTIFICATIONS

  • Board Certified in Internal Medicine
  • Board Certified in Adult Echocardiography
  • Board Certified in Nuclear Medicine
  • Board Certified in Cardiovascular Medicine
  • Board Certified in Interventional Cardiology
  • 2020 BLS and ACLS re-certified

PUBLICATIONS

  1. Kattamis AC, Kelly KM, Ohene-Frempong K, Reilly MP, Keller M, Cubeddu R, Adachi K. Surrey S, Fortina P. HB OSLER [β145 (HC2) TYR→ASP] results from post translational modification. Hemoglobin 1997 Mar; 21(2), 109-20.

  2. Cubeddu LX, Hoffmann IS, Jimenez E, Roa CM, Cubeddu RJ, Palermo C, Baldonedo RM. Insulin and blood pressure responses to changes in salt intake. Journal of Human Hypertension 2000 Apr; 14, Suppl 1, S32-S35.

  3. Cubeddu LX, Alfieri AB, Hoffmann IS, Jimenez E, Roa CM, Cubeddu R, Palermo C, Baldonedo RM. Nitric oxide and salt sensitivity. Am J Hypertens. 2000 Sep; 13(9):973-979

  4. Cubeddu RJ, Mann T, et al. Transradial approach for coronary stenting. Cath Lab Digest 2000 Nov; Vol 8(11), 17-22

  5. Castejon AM, Hoffmann IS, Jimenez E, Cubeddu RJ, Baldonedo RM, Cubeddu LX. Differential blood pressure effects of oral glucose and intravenous l-arginine in healthy lean normotensive and obese hypertensive subjects. Journal of Human Hypertension, 2002 Mar;16 Suppl 1:S133-6

  6. Cubeddu RJ, Arrowood M, Mann T, Gough M. Successful left internal mammary artery intervention from the left radial approach after failure from the femoral approach Online Radial Force. http://www.radialforce.org/publicationsitem09.htm

  7. Cubeddu RJ, Arrowood M, Mann T. Successful coronary stenting in a patient with heparin-induced thrombocytopenia using bivalirudin anticoagulation: A case report. Journal of Invasive Cardiology, Sep 2002.

  8. Mann T, Cubeddu RJ, Raynor L, Bowen J, Schneider JE, Rose G, Cubeddu G, Raza JA, Jobe RL, Newman W, Zellinger M. Coronary stenting in stable patients: identification of a low risk subgroup that may not require adjunctive use of glycoprotein IIb/IIIa inhibitors. Catheter Cardiovascular Interventions. 2003 Apr;58(4):459-66

  9. Cubeddu LX, Cubeddu RJ, Heimowitz T, Restrepo B, Lamas GA, Weinberg GB. Comparative lipid-lowering effects of policosanol and atorvastatin: a randomized, parallel, double-blind, placebo-controlled trial. American Heart Journal, 2006 Nov;152 (5):982.e1-5

  10. Hallak OK, Cubeddu RJ, Griffith RA, Reyes BJ. The use of the D-Stat dry bandage for the control of vascular access site bleeding: A multicenter experience in 376 Patients. Cardiovascular Interventional Radiology, 2007 Jul-Aug;30(4):593-600.

  11. Cubeddu RJ, Pomerantsev E, Palacios IF. The Ventura Control Catheter: A useful armament for the interventionalist. Online publication: tctmd.com. October 8, 2007.

  12. Cubeddu RJ, Wood FO, Saylors EK, Mann T. Isolated disease of the ostial left anterior descending or circumflex artery: Management using a left main stenting technique. Clinical outcome at 2 years. Journal of Invasive Cardiology, 2007 Nov;19 (11):457-61.

  13. Cruz-Gonzalez I, Cubeddu RJ, Sanchez-Ledesma M, Cury RC, Coggins M, Maree AO, Palacios IF. Left atrial appendage exclusion using an amplatzer. International Journal of Cardiology, 2008, Feb 11.

  14. Erick Avelar, Cubeddu RJ, Rodrigo Pale, Hiram Bezerra, Ronen Durst, and Wilfred Mamuya. 54-year-old man with abnormal nuclear stress test. MGH Cardiovascular Images. http://www.mghcardiovascimages.org/index.

  15. Kiernan TJ, Yan BP, Cruz-Gonzalez I, Cubeddu RJ, Caldera AE, Kiernan GD, Gupta V. Pharmacological and cellular therapies to prevent restenosis after percutaneous transluminal angioplasty and stenting. Cardiovasc Hematol Agents Med Chem. 2008 Apr;6(2):116-24.

  16. Cubeddu RJ, Conde CA. The aorta in osteoporosis. Images in Clinical Medicine. NEJM, May 29, 2008; 358 (22): 2388.

  17. Sanchez-Ledesma M, Cruz-Gonzalez I, Sanchez PL, Martin-Moreiras J, Jneid H, Rengifo-Moreno P, Cubeddu RJ, Inglessis I, Maree AO, Palacios IF. Impact of concomitant aortic regurgitation on percutaneous mitral valvuloplasty: immediate results, short- and long-term outcome. Am Heart J 2008; Aug; 156(2):361-6.

  18. Vishal G, Truong QA, Okada DR, Kiernan TJ, Yan BP, Cubeddu RJ, Abbara A, MacGillivray TE, Palacios IF. Giant coronary artery aneurysm and arteriovenous fistula. Circulation. 2008 Nov 25;118(22):2304-7.

  19. Kiernan TJ, Yan BP, Cubeddu RJ, Rengifo-Moreno P, Gupta V, Inglessis I., Jaff MR, Schainfeld RM, Palacios IF. May-Thurner syndrome in patients cryptogenic stroke and patent foramen ovale: an important clinical association. Stroke. 2009 Apr;40(4):1502-4

  20. Johri AM, Yared K, Durst R, Cubeddu RJ, Palacios IF, Picard MH, Passeri J. Three-dimensional echocardiographic-guided repair of severe paravalvular regurgitation in a bioprosthetic and mechanical mitral valve. Eur J Echocardiogr. 2009 Mar 8

  21. Jneid H, Cruz-Gonzalez I, Sanchez-Ledesma M, Maree AO, Vigo S, Pal Otero J, Cubeddu RJ, Leon ML, Rengifo-Moreno P, Inglessis I, . Impact of periprocedural mitral regurgitation on outcome after percutaneous mitral valvuloplasty for mitral stenosis. Am J Cardiol, 2009 Oct 15;104(8):1122-7.

  22. Cubeddu RJ, Hani J, Cruz-Gonzalez I et al. Antegrade versus retrograde percutaneous aortic balloon valvuloplasty. Immediate, short- and long-term outcome at 2-years. Catheter Cardiovasc Interv. Apr 13, 2009

  23. Kiernan TJ, Yan BP, Cubeddu RJ, Igor F. Palacios et al. Coronary perforations in the contemporary interventional era. J Interv Cardiol. May 6, 2009.

  24. Diaz T, Cubeddu RJ, Rengifo-Moreno P, Cruz-Gonzalez I, Inglessis I, Palacios IF. Management of residual shunts after initial PFO closure: a single center experience with immediate and long-term follow-up. Catheter Cardiovasc Interv. 2010 Jul1;76 (1):145-50.

  25. Cubeddu RJ, Cruz-Gonzalez I, Kiernan TJ, Leinbach R, Truong QA, Rosenfield K, Pomerantsev E, Palacios IF. ST elevation myocardial infarction mortality in a major academic center: “on” vs. “off” hours. J. of Invasive Cardiol 2009 Oct;21(10):518-23.

  26. Bernal J, Cubeddu RJ, Igor Palacios, Ignacio Inglessis. et al. Persistent left superior vena cava. Case illustration. Cardiosource, 2009.

  27. Cubeddu RJ, Inglessis I, Palacios IF. Structural Heart Disease: an emerging field in cardiovascular medicine: A Clinical Perspective. J Invasive Cardiol. 2009 Sep;21(9):478-82.

  28. Witzke C, Don CW, Cubeddu RJ, Ignacio Inglessis, Igor F. Palacios et al. Impact of rapid ventricular pacing during percutaneous balloon aortic valvuloplasty in patients with critical aortic stenosis: Should we be using it? Catheter Cardiovasc Interv 2009 Oct 6

  29. Truong QA, Cubeddu RJ, et al. Double-chambered right ventricle and situs inversus with dextrocardia. Circulation, Clinical Images, 2010 Mar 9;121(9):e229-32.

  30. Don C. Witzke C. Cubeddu RJ, Ignacio Inglessis, Igor Palacios et al. Comparison of procedural and in-hospital outcomes of percutaneous balloon aorticvalvuloplasty in patients >80 years versus patients < or = 80 years. Am J Cardiol. 2010 Jun 15;105(12):1815-20

  31. Feldman T, Ruiz CE, Hijazi ZM et al. The SCAI Structural Heart Disease Council: toward addressing training, credentialing, and guidelines for structural heart disease interventions. Catheter Cardiovasc Interv. 2010 October;76(4):E87-9.

  32. Cruz-Gonzalez I, Jneid H, Cubeddu RJ, Ignacio Inglessis, Igor Palacios et al. Difference in outcome among women and men after percutaneous mitral valvuloplasty. Catheter Cardiovasc Interv. 2011 Jan 1;77(1):115-20.

  33. Cubeddu RJ, Hijazi ZM. Bailout perventricular pulmonary valve implantation following failed percutaneous attempt using the Edwards sapien THV. Catheter Cardiovasc Interv. February 1, 2011.

  34. Don C. Witzke C. Cubeddu RJ, Ignacio Inglessis, Igor Palacios et al. Patients with small left ventricular size undergoing balloon aortic valvuloplasty have worse intraprocedural outcome. Catheter Cardiovasc Interv. 2012 Aug 23.

  35. Cubeddu RJ, Lago R et al. Use of the Impella 2.5 alone, after or in combination with IABP in patients with cardiogenic shock. Case description and review of the literature. Eurointervention, 2012. Apr;7(12):1453-60

  36. Horvath S, Nass N., Correa L, Jaraki A, Chiravuir R, Cubeddu RJ. Impact of pre-hospital activation strategy in STEMI patients undergoing PCI: single center community hospital experience. Crit Pathways Cardiol. 2012 Dec;11(4):186-92.

  37. Garg R. Cubeddu RJ. Transhepatic closure of atrial septal defect in patient with severe pulmonary hypertension. Peds Int. 2012

  38. Cubeddu RJ, Don C, Cristian Witzke, Ignacio Inglessis, Igor Palacios et al. LVEDP as independent predictor of outcome in patients undergoing BAV. Catheter Cardiovasc Interv. 2012 April 18.

  39. Cubeddu RJ, Palacios IF et al. Outcome of patients with STEMI undergoing primary PCI during on-versus off-hours Percutaneous Coronary Intervention During On- Versus Off-hours (A Harmonizing Outcomes With RevasculariZatiON and Stents in Acute Myocardial Infarction [HORIZONS-AMI] Trial Substudy). Am J Cardiol. Jan 19, 2013 Apr 1;111 (7):946-54.

  40. Cruz-Gonzalez I, Semigram MJ, Cubeddu RJ, Palacios IF. Effect of Elevated Pulmonary Vascular Resistance on Outcomes After Percutaneous Mitral Valvuloplasty. Am J Cardiol. 2013; May 16

  41. Cubeddu RJ, Babin I, Inglessis I. The off-label use of the Amplatzer muscular VSD occluder for large patent ductus arteriosus: a case report and review. Cardiovasc Interv Ther. 2013 Nov 8.

  42. Inglessis I., Rengifo P., Cubeddu RJ, Pomeranz E, Cruz-Gonzalez I, Palacios IF, et al. Long-term Experience and Outcomes with Transcatheter Closure of Patent Foramen Ovale. JACC Cardiovasc Interv. 2013 Nov;6(11):1176-83.

  43. Cubeddu RJ, Vishal G. Simultaneous Kissing stent in a patient with severe bifurcation pulmonary vein stenosis. Cath Cardiovasc Interv Feb 1, 2015.

  44. Cubeddu RJ, Crespo HJ, Novaro GM. Retrograde transmitral paravalvular leak closure through an antegrade transseptal approach: A novel Technique. Catheter Cardiovasc Interv. 2018 Jan 13.

  45. Hatfield SA, Nores MA, Cubeddu RJ, Stameou SC et al. Predictors and outcomes of stroke after transcatheter aortic valve replacement. J Card Surg. 2020 Jan; 35 (1): 21-27

  46. Cubeddu RJ, Sarkar A, Navas V., Navia JL. ‘Minimalist approach’ for transcatheter mitral valve replacement under conscious sedation and intracardiac echocardiography. Eur Heart J, April 27, 2020 Apr 24;4(3):1-5

  47. Pino JE, Shah V, Cubeddu RJ, Chait R et al. The utility of pulmonary function testing in the preoperative risk stratification of patient undergoing transcatheter aortic valve replacement. Catheter Cardiovascular Interv. 2020 May 1; 95(6):E179-E185

  48. Milla C., Fonseca M., Cubeddu R., Rosenthal R. et al. The impact of ethnicity on cardiovascular risk reduction and heart age after bariatric surgery. Obes Surg. 2020 May; 30(5): 1679-1684.

  49. Hanna N. Carmona A, Crespo H, Cubeddu RJ. Mechanical tricuspid balloon ‘valvuloplasty’ in a prohibitive risk patient with cardiogenic shock: a case report. Eur Heart J Case Rep. 2020 May 3; 4(3):1-4

  50. Sadler D, Chaulagain C, Cubeddu R, Nahleh Z, et al. Practical and cost-effective model to build and sustain a cardio-oncology program. Cardio-oncology. 2020 Jul 16;6:9

  51. Cubeddu RJ, Sanchez AM, Perez E, Sleiman J, Lopez D, Navia. First Experience Using a Nonfenestrated Cardioform Septal Occluder for Closure of Giant Mitral Paravalvular Leak. JL, J Am Coll Cardiol Case Rep. 2020 Mar, 2 (3) 468-472.DOI:10.1016/j.jaccas.2019.12.027

  52. Cubeddu RJ, Asher C, Kapadia S., Leon M., Svensson L et Impact of transcatheter aortic valve replacement on severity of chronic kidney disease”. J Am Coll Cardiol. 2020 Sep 22; 76 (12): 1410-1421.

  53. Brozzi N., Cubeddu RJ, Navia JL et al. et al. Successful Mobile Extracorporeal Membrane Oxygenator for COVID-19 Severe Respiratory Failure.” Journal of Cardiac Surgery. October, 2020

  54. Sleiman J, Lewis JA, Sanchez, AM, Baez-Escudero JL, Navia JL, Asher, CR, Cubeddu RJ. Management of peri-device leak following left atrial appendage closure: A Systematic Review. Catheter Cardiovascular Interv. Feb, 2021;1-9

  55. Cubeddu LX, Cubeddu RJ. Early remdesivir treatment in COVID-19: Why wait another day? J Med Virol. 2021, Jul;23(7):4078-4080.

  56. Sleiman J, Lewis A, Cubeddu RJ. Cardioform septal occluder for closure of a peridevice leak after initial Watchman implantation. Cureus, June 4, 2021.

  57. Lewis A, Hakemi E., Lopez D., Cubeddu RJ. Mitraclip repair of right-sided atrioventricular valve in patient with congenitally corrected transposition of the great arteries. European Heart Journal, Case Reports. Aug, 2021.

  58. Santiago G., Cubeddu RJ, et al. Impact of TAVR vs. SAVR in patients with underlying chronic kidney disease. JACC Interventions, Aug 2021.

  59. Perez-Villa B, Cubeddu RJ, Brozzi N. et al. Transition to heart transplantation in post-myocardial infarction ventricular septal rupture: a systemic review. Heart Fail Rev. Oct 2021.

  60. Garcia S, Cubeddu RJ, Hahn RT et al. 5-Year outcome comparing surgical vs transcatheter aortic valve replacement in patients with chronic kidney disease. J Am Coll Cardiol Cardiovasc Interven. Sep 2021.

  61. Patel SP, Solomon BJ, Cubeddu RJ et al. Right ventricular failure manifesting in corona virus disease 2019 respiratory distress syndrome: A call to transition from VV ECMO to RVAD ECMO. J Cardiothoracic Vasc Anesthesia. Feb 2022.

  62. Lewis A, Hakemi E, Cubeddu RJ. Mitraclip repair of right-sided atrioventricular valve in a patient with congenitally corrected transposition of the great arteries: Case Report. Eur Heart J. Case Report. Jan 2022.

  63. Patel SP, Solomon BJ, Cubeddu RJ et al. Uninterrupted continuation of VV-ECMO without anticoagulation for 44 days in COVID 19 ARDS: A precarious quandary. J Cardiothoracic Vasc Anesthesia. Apr 2022.
  1. PARTNER I investigators. N Engl J Med. 2012 May 3;366 (18):1696-704. Role: Co-Investigator (Site MGH, 2007-2009) Makkar RR, Fontana GP, Jilaihawi H, et al.

  2. Søndergaard L, Kasner SE, Rhodes JF, et al. REDUCE Trial Investigators. N Engl J Med. 2017 Sep 14;377(11):1033-1042. Co-Investigator (Site: Aventura Hospital and Medical Center, FL, 2013-2016)

  3. Mack MJ, Leon MB, Thourani VH, et al. PARTNER 3 Trial Investigators. N Engl J Med. 2019 May 2;380(18):1695-1705. Co-Investigator (Site JFK Medical Center 2017-2018)

  4. ASSURED Trial Investigators. Use of Cardioform ASD Gore Occluder for the percutaneous closure of ASD. CO-Investigator (Site: Miami Children’s Hospital)
  1. Cubeddu RJ, Truong QA, Rengifo- Moreno P et al. Directional coronary atherectomy: A time for reflexion. Should we let it go? EuroIntervention. 2009 Sep;5(4):485-93.

  2. Kiernan TJ, Cubeddu RJ et al. No reflow phenomenon in the coronary circulation. Review. Cardiovasc Hematol Agents Med Chem. 2009 Jul;7(3):181-92.

  3. Cubeddu RJ, Palacios IF. Percutaneous Strategies for Mitral Valve Repair: Text Book of Percutaneous Cardiac Interventions Beyond Stenting: Tips and Tricks for New Technology. Book Chapter; Editor Manuel Sabates; 2008.

  4. Cubeddu RJ, Palacios IF. Percutaneous heart valve replacement and repair: Advances and future potentials. Review. Expert Rev of Cardiovasc Ther. 2009 Jul;7(7):811-21.

  5. Cubeddu RJ, Palacios IF. Percutaneous techniques for mitral valve disease. Book Chapter. Cardiology Clinic of North America, 2010 Feb;28(1):139-53.

  6. Lago R, Cubeddu RJ, Palacios IF. Percutaneous approach to mitral valvular disease. Cardiology Clinics of North America, 2012.

  7. Cubeddu RJ, Witzke C. Percutaneous balloon aortic valvuloplasty. Manual de Hemodinamia (Handbook of Interventional Cardiology). Second Edition. Madrid, Spain Edition. 2013.

  8. Matthew Wu, Sankalp Patel, Creighton Don, Cubeddu RJ. Mitral Perivalvular Leak: Imaging and Interventional Approaches. Textbook of Structural Heart Disease Interventions, 2022
  1. Kobayashi M, Cubeddu RJ. Semi-automated analysis of the β-globin gene mutations using a microtiter-based colorimetric assay. 20th Annual Meeting of the National Sickle Cell Disease Program. Boston, 1995. (Abstract)

  2. Guevara BH, Cubeddu RJ et al. Neurotoxicity of kainic acid on cholinergic neurons of the dorsal and ventral corpus striatum in rats. Colombian Pharmacology Annual Meeting, 1997. (Poster/Abstract)

  3. Cubeddu LX, Cubeddu RJ et al. Multiple cardiovascular risk factors associated with salt sensitivity. 5Th International Symposium on Multiple Risk Factors in Cardiovascular Disease. Venice, Italy. October 1999. (p31 Abstract)

  4. Castejon AM, Cubeddu RJ. Comparative effects of l-arginine infusion and oral glucose load in plasma insulin levels. Annual Meeting; Nov 2000. Acta Cientifica Venezolana Vol 51:Suplemento 2:p92 (Abstract)

  5. Castejon AM, Cubeddu RJ et al. Insulinotropic effect of l-arginine and glucose in control subjects and in hypertensive, obese, hyperinsulinemic patients. Proceedings of the XV Scientific Meeting of the American Society of Hypertension, NY, NY. Am J Hypertens. 113: #4, part2, p96A, 2000. (Abstract)

  6. Cubeddu RJ, T Mann et al. Factors in post-procedure MI in coronary stenting: is guidewire time as important as antiplatelet strategy? Transcatheter Cardiovascular Therapeutics (TCT) meeting, Washington, DC. October 2000. (Abstract)

  7. Cubeddu RJ. Ideopathic CD+4 T-lymphocytopenia: Unique cases mimicking AIDS. American College of Physicians, Associates Meeting; Orlando, FL. March 9-10, 2001. (Oral Presentation)

  8. Martin F, RJ Cubeddu, Palacios IF et al. Percutaneous transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Immediate and long-term results. 14th World Congress of Cardiology, Sidney, Australia, May 7, 2001. (Oral presentation)

  9. Cubeddu RJ, Martinez R. Severe extra-pulmonary manifestations of Mycoplasma Pneumoniae infections: should early antibiotic therapy be used?: a case series and review. 40th annual meeting of the Infectious Disease Society of America, Chicago, IL. October 24-27, 2002. (Poster)

  10. Cubeddu RJ, Tuda C. Reversible pericardiomyopathy and acute heart failure due to Mycoplasma Pneumoniae: Case Report and Review. American College of Physician Meeting. Boca Raton, FL. September 20-24,2002. (Poster)

  11. Madera S, Cubeddu RJ. Clinically isolated syndrome of multiple sclerosis: a rare presentation and diagnostic challenge. Florida Chapter of the American College of Physician Meeting. St. Petersburg, FL. September 12-14, 2003. (Poster)

  12. Hani J, Cruz-Gonzalez I, Sanchez-Ledesma M, Pal OJ, Vigo S, Cubeddu RJ, Maree AO, Palacios IF. Gender differences in procedural and clinical outcomes after percutaneous balloon mitral valvuloplasty. ACC-SCAI meeting, Chicago, 2008.(Asbtract)

  13. Cubeddu RJ, Cruz-Gonzalez I, Kiernan TJ, Rosenfield K, Palacios IF, Pomerantsev E. Relación entre la hora de ingreso y la mortalidad intrahospitalaria en pacientes ingresados con infarto agudo del miocardio con elevación del segmento ST y sometidos a angioplastia primaria. Sociedad Venezolana de Cardiología; Margarita, 14-17 de Julio, 2008. (Oral Presentation)

  14. Cubeddu RJ, Cruz-Gonzalez I, Kiernan TJ, Rosenfield K, Gold HK, Palacios IF, Pomerantsev E. Analysis of Arrival Time on Mortality in Patients Undergoing Primary Percutaneous Coronary Intervention for Acute ST Elevation Myocardial Infarction. Cardiac Revascularization Meeting, Washington, DC 2008. (Poster)

  15. Cubeddu RJ, Cruz-Gonzalez I, Martín MJ, Sánchez LM, Jneid H, Inglessis I, Martín LC, Palacios IF. Complicaciones, resultados inmmediatos y a largo plazo de la valvuloplastia aórtica percutánea según Congreso de la Sociedad Española de Cardiología, Bilbao 9-11 October, 2008. (Abstract)

  16. H. Jneid, S. Vigo, AO. Maree, I. Cruz-Gonzalez, J. Pal Otero, Cubeddu RJ, G. Moukarbel, K. Rosenfield, E. Pomerantsev, I. Palacios. Characteristics and outcomes of patients with angiographic drug-eluting and bare-metal stent thrombosis. European Society of Cardiology Meeting, Sep, 2008. (Abstract)

  17. Kiernan TJ, Yan BP, Cubeddu RJ, Cruz-Gonzalez I, Rosenfield K, Palacios IP. Coronary perforations during percutaneous coronary intervention: a contemporary analysis. European Society of Cardiology Congress 2008; (Abstract)

  18. H. Jneid, I. Palacios, AO. Maree, I. Cruz-Gonzalez, Cubeddu RJ, N. Silva, S. Vigo, E. Pomerantsev, S. Houser. Histological evidence of impaired vascular healing of restenotic sirolimus-eluting coronary stents: an antemortem clinical study. European Society of Cardiology Meeting, Sep, 2008. (Abstract)

  19. Kiernan TJ, Yan BP, Cubeddu RJ, Rengifo-Moreno P, Inglessis I, Schainfeld RM, Palacios IF. Patent Foramen Ovale, Cryptogenic Stroke and May-Thurner syndrome: a retrospective analysis. TCT October 12-17, 2008. Washington, DC. (Abstract)

  20. Kiernan TJ, Yan BP, Cubeddu RJ, Cruz-Gonzalez I, Rosenfield K, Palacios IF. Coronary artery perforation in the current era of percutaneous coronary intervention. TCT October 12-17, 2008. Washington, DC. (Abstract)

  21. Mingming Ning, IF Palacios, D. Sena, I. Inglessis, M. McNamara, M. Lievens, Z. Demirjian, I. Cruz-Gonzalez, Pablo Rengifo, Cubeddu RJ, R. Schainfeld, D. McMullin, W. Dec, E. Grabowski, Eng H Lo, F. Buonanno, “Economy Class Strokes” – The Association Between Long Distance Travel and Patent Foramen Ovale. AHA- International Stroke meeting 2008. (Abstract)

  22. Rengifo-Moreno P, Buonanno FJ, Cubeddu RJ, Inglessis I, Palacios IP. Efficacy and safety of percutaneous patent foramen ovale closure in patients with thrombophilia. AHA meeting, New Orleans, 2008. (Asbtract)

  23. Horvath S, Cubeddu RJ. Increased mortality after primary percutaneous coronary intervention for acute ST segment elevation myocardial infarction during off-hours. AHA meeting, New Orleans, Nov 12, 2008. (Abstract)

  24. Diaz T, Rengifo-Moreno P, Cubeddu RJ, Azpurua F, Cruz-Gonzalez I, Solis J, McNamara M, Inglessis I, Palacios IF. Second device implantation in patients with residual shunt after percutaneous patent foramen ovale closure. Submitted to ACC meeting-2009. (Asbtract)

  25. Rengifo-Moreno P, Cubeddu RJ, Cruz-Gonzalez I, Diaz T, Azpurua F, Ning M, McNamara M, Inglessis I, Buonanno FS, Palacios IP. Catheter closure of patent foramen ovale is equally beneficial for migraineurs with or without aura. ACC 2009. (Asbract)

  26. Cubeddu RJ, Inglessis I. Endovascular treatment of pulmonary artery stenosis secondary to Takayasu’s Arteritis. Structural Case Presentations. EuroPCR, Barcelona, Spain May 19th-22nd, 2009. (Abstract)

  27. Witzke C., Don C., Cubeddu RJ, I. Inglessis, IF Palacios et al. Rapid ventricular pacing during aortic valvuloplasty is safe but associated with lower procedural success. Transcatheter cardiovascular therapeutics (TCT) meeting; San Francisco, CA Sept 21-26, 2009. (Poster Presentation)

  28. Cubeddu RJ, Rengifo P, Solis-Martin J, Lopez T, Inglessis I, Palacios IF. Percutaneous closure of patent foramen ovale in older patients with cryptogenic stroke: long-term outcome at 2 years. Solaci 2010 (Poster Presentation)

  29. Cubeddu RJ, Blankenship J, Dangas G, Palacios IF, Stone GW, Mehran R. STEMI Presentation during Off-Hours does not compromise response times or mortality. HORIZONS-AMI substudy. Oral Presentation. Transcatheter Therapeutic Meeting, Washington DC. September 22, 2010. (Abstract # 87)

  30. Cubeddu RJ, Rodrigo Lago, Ivan Mendoza, Ann F Lovett, Katya Zelevinsky, Ashley M Crane, Christian Witzke, Sharon-Lise Normand, Eugene Pomerantsev, Igor F Palacios. No Mortality Advantage of “On” versus “Off”- hours Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: Results from the Massachusetts Data Analysis Center Registry. Poster Presentation. AHA Meeting. Chicago, Illinois, Nov 14, 2010 (Abstract)

  31. Horvath S, Cubeddu RJ et al. Benefits of pre-hospital STEMI team activation on in-hospital mortality, door-to-balloon time and infarct size. International Academy of Cardiology – XVI World Congress on Heart Disease – Annual scientific session. Vancouver, Canada July 23-26, 2011 (Poster Presentation)

  32. Horvath S, Cubeddu RJ et al. Impact of Pre-Hospital Activation Strategy On Revascularization Time, Left Ventricular Ejection Fraction and Mortality In Patients With ST-Elevation Myocardial Infarction. TCT meeting. San Francisco, CA, November 7-11, 2011. (Asbtract)

  33. Lago RM, Inglessis I, Cubeddu RJ et al. Percutaneous Treatment of Complex Atrial Septal Defects in Adults using Multiple Closure Devices: Clinical and Echocardiographic Results. M3 Meeting 2011, Miami, FL (Poster presentation)

  34. Cubeddu RJ, Horvath S et al. LVEDP as independent predictor of outcome in patients undergoing BAV. M3 Meeting, Miami, FL – October, 2011 (Poster). Recognition for “Best Poster Award”

  35. Horvath S; Cubeddu RJ. ACC Meeting March, 2015- San Diego, CA – Poster presentation – Transhepatic ASD closure in a patient with interrupted IVC and Eisenmenger Physiology; (Poster Presentation).

  36. Herrera J, Cubeddu RJ, Palacios I. et al. Acute hemodynamics effects of percutaneous transluminal caval flow restriction with caval counterpulsation balloon in the first six humans with ischemic an non-ischemic congestive heart failure. TCT San Francisco, October, 2015. (Asbstract)

  37. Chainani, V; Cubeddu RJ. Bailout balloon mitral valvuloplasty in patient with calcific mitral stenosis, severe pulmonary hypertension and cardiogenic shock. Valve Heart Summit. 2015. (Abstract)

  38. Cubeddu RJ, Azad H, et al. Use of the Edwards Sapien valve for management of acute and chronic CoreValve paravalvavular leak. Miami Valves Meeting. May 2017. (Poster Presentation)

  39. Cubeddu RJ, Crespo H et al. Sinus of Valsalva diameter as an aid to valve sizing in transcatheter aortic valve replacement, Accepted; Annual TVT meeting CRF 2017. (Poster Presentation)

  40. Cubeddu RJ, Crespo HJ, Novaro GM. Retrograde transmitral paravalvular leak closure through an antegrade transseptal. TCT Denver, CO 2017 Abstract Poster Presentation.

  41. Cubeddu RJ, Kapadia S, Blackstone E, Leon M, Svensson L. TAVR improves rather than worsens kidney function. Results for PARTNER Trial investigators. San Diego, TCT 08, 2018 (Oral Abstract Moderator)

  42. Crespo H, Flocco G, Cubeddu RJ et al. Clinical significance of PFO in patients undergoing liver transplantation; a retrospective multicenter study. Cleveland Clinic. TCT 2018. (E- poster)

  43. Sadler D, Cubeddu RJ et al. Starting a cardio-oncology program. Results of a Single Center Experience. Cleveland Clinic Florida. Cardio-oncology Summit 2018. (Abstract)

  44. Carmona A, Hanna N, Cubeddu RJ et al. Tricuspid valvuloplasty in a mechanical prosthesis. Oral Presentation. ACC Meeting, New Orleans, 2019

  45. F. Ramos-Tuarez, A. Alrifai, E. Grajeda, M. Kabach, J. Pino, P. Dayanand, S. Sundaravel, Eduardo Venegas, L. Lovitz, M. Rothenberg, C. Faber, Cubeddu RJ, M. Nores. The association between contrast dose and renal function in TAVR. JACC Vol 71, Issues 11, Pages 1150, 2018.

  46. Kabach M, Alrifai A, Pino J, Dayanand P, Cubeddu RJ, Marcos N, Fanari Z. The impact of gradient and flow on the outcome of TAVR in severe aortic stenosis with preserved left ventricular ejection fraction. JACC 2018-03-10. Vol 71, Issue 11, Pages A1343

  47. Sundaravel S, Pino J, Alfari A, Grajeda E, Faber C, Rothenberg M, Lovitz L, Daniels G, Dayanand P, Cubeddu RJ, Marcos N. Outcomes in patients with severe LV dysfunction and acute decompensated heart failure undergoing emergent TAVR. JACC, 2018-03-10; Vol 71, Issue 11, Pages A 1340

  48. Alfari A, Kabach M, Grajeda E, Faber C, Rothenberg M, Lovitz L, Daniels G, Dayanand P, Cubeddu RJ, Marcos N. Long term outcome of TAVR on paradoxical low flow low gradient aortic stenosis. JACC 2018-03-10. Vol 71, Issue 11, Pages A1335.

  49. Grajeda E, Alfari A, Kabach M, Grajeda E, Faber C, Rothenberg M, Lovitz L, Daniels G, Dayanand P, Cubeddu RJ, Marcos N. Reduction in radiation and contrast dose in TAVR over time: a single center experience.

  50. Alfari A, Kabach M, Grajeda E, Faber C, Rothenberg M, Lovitz L, Daniels G, Dayanand P, Cubeddu RJ, Marcos N. The impact of beta blockers on TAVR outcomes. JACC 2018-02-26, Vol 11, Issue 4, Pages S48

  51. Jesus E. Pino, MD., Pedro, Torres, MD., Fergie Ramos Tuarez, MD, Pradeep Dayanand, M.D., Nakeya Dewaswala, M.D., Kai Chen, M.D., Lovitz, Lawrence, MD, Mark Rothenberg, MD, Cubeddu RJ, MD, Marcos Nores, MD,Robert Chait MD. Optimal use of anesthetics in nonagenarians undergoing Transcatheter Aortic Valve Implantation. SCAI meeting. Las Vegas 05.2019

  52. Pedro Torres MD, Jesus Pino MD, Baher Al Abassi MD, Nakeya Dewaswala MD, Pradeep Dayanand MD, Fergie Ramos MD, Gustavo Avila MD, Lawrence Lovitz MD, Mark Rothemberg MD, Cubeddu RJ, Robert Chait MD. Impact of ERAS protocol in nonagenarians undergoing TAVR. SCAI meeting. Las Vegas 05.2019

  53. Jesus E Pino, MD., Pedro Torres, MD., Fergie Ramos Tuarez, MD, Kai Chen, MD, Mohammed Kabach, MD, Abdullah Alrifai, MD, Lawrence Lovitz, MD., Cubeddu RJ, Mark Rothenberg, MD, Robert Chait, MD, Marcos Nores, MD. Neurohormonal Inhibition and Outcomes in TAVR. SCAI meeting. Las Vegas 05.2019

  54. Kai Chen, MD., Abdullah Alrifai, MD., Mohammed Kabach, MD., Jesus E Pino, MD., Pedro Torres MD., Elie Donath, MD., , Lawrence Lovitz, MD., Mark Rothenberg, MD., Cubeddu RJ, Robert Chait, MD, Marcos Nores, MD. Outcomes of Low-risk patients undergoing Transcatheter Aortic Valve replacement for Severe Aortic stenosis, A single Center experience. SCAI meeting. Las Vegas 05.2019

  55. Kai Chen, MD., Abdullah Alrifai, MD., Mohammed Kabach, MD, Jesus E Pino, MD, Elie Donath, MD, Lawrence Lovitz, MD, Mark Rothenberg, MD, Cubeddu RJ, MD, Robert Chait, MD, Marcos Nores, MD.The predictive value of left ventricular end-diastolic pressure on outcomes in patients undergoing Transcatheter Aortic Valve replacement. SCAI meeting. Las Vegas 05.2019

  56. Ghiloni N., Cubeddu RJ. Percutaneous closure of Vertical Vein in patients with severe hypoxemia from right to left shunting. Submitted to PICS Meeting 2019.

  57. Sarkar A., Cubeddu RJ. First experience using a “Minimalist Approach” to Transcatheter Mitral Valve Replacement with Intracardiac Echocardiography. TCT September 25-29, 2019.

  58. Muñoz, E., Del Cid Fratti, J., Sleiman J., Go, R., Salazar, M., and Cubeddu RJ. Impact of ESRD on In-hospital Mortality after Transcatheter Mitral Valve Repair: A National Inpatient Sample Database Study. Society for Cardiovascular Angiography and intervention. 2019, May; Volume 93(S2): (188-189).

  59. Sleiman J, Zandiyeh M, Alonso M, Miret R, Bhansali H, Miranda D, Perez E, Hanna N, Hernandez L, Leung K, Ghiloni N, Navas E, Asher C, Cubeddu RJ. Mitral balloon valvuloplasty of bioprosthetic valve: an alternative when a valve-in-valve procedure is not an option. Journal of the American College of Cardiology. Volume 75, Issue 11 Supplement 1, March 2020. DOI: 10.1016/S0735-1097(20)34006-7

  60. Leung K, Bhansali H, Ghiloni N, Hernandez L, Hanna N, Perez E, Miranda D, Sleiman J, Cubeddu RJ, Navas E. Transseptal VSD closure in a patient with mechanical aortic and tricuspid valves. Journal of the American College of Cardiology. Volume 75, Issue 11 Supplement 1, March 2020. DOI: 10.1016/S0735-1097(20)32999-5

  61. Bhansali H, Lewis A, Ghiloni N, Hanna N, Hernandez L, Leung K, Miranda D, Sleiman J, Perez E, Shivazad A, Stadtlander K, Cubeddu RJ, Navas E, Helguera M, Baez-Escudero J, Pinski S. Percutaneous retrieval of an embolized vegetation from pulmonary artery after icd lead extraction. Journal of the American College of Cardiology. Volume 75, Issue 11 Supplement 1, March 2020. DOI: 10.1016/S0735-1097(20)33256-3

  62. Bhansali H, Lewis A, Ghiloni N, Hanna N, Hernandez L, Leung K, Miranda D, Sleiman J, Perez E, Shivazad A, Stadtlander K, Cubeddu RJ, Navas E, Helguera M, Baez-Escudero J, Pinski S. Percutaneous retrieval of an embolized vegetation from pulmonary artery after icd lead extraction. Journal of the American College of Cardiology. Volume 75, Issue 11 Supplement 1, March 2020. DOI: 10.1016/S0735-1097(20)33256-3

  63. Sanchez AM, Perez E, Sleiman J, Lopez D, Navia JL, Ghiloni N, Bhansali H, Hanna N, Leung K, Hernandez L, Miranda D, Navas E, Cubeddu RJ. First experience using a non-fenestrated cardioform septal occluder for closure of a giant mitral paravalvular leak. Journal of the American College of Cardiology. Volume 75, Issue 11 Supplement 1, March 2020. DOI: 10.1016/S0735-1097(20)32938-7

  64. Cubeddu RJ, Garcia S., Leon M. et al. Impact of acute kidney injury after surgical and transcatheter aortic valve replacement in intermediate risk patients with chronic kidney disease (#16824). ACC’s 70th Annual Scientific Session, May 15-17, 2021, Atlanta Georgia.

  65. Garcia S., Cubeddu RJ, Leon M. Structural valve deterioration of transcatheter versus surgical aortic valves in patients with chronic kidney disease: Insights from the PARTNER 2D Trial and Sapien 3 intermediate risk registry (#16925). ACC’s 70th Annual Scientific Session, May 15-17, 2021, Atlanta Georgia.

  66. Garcia S, Cubeddu RJ, Leon M. Five-year outcomes comparing surgical versus transcatheter aortic valve replacement in intermediate risk patients with chronic kidney disease (#17250). ACC’s 70th Annual Scientific Session, May 15-17, 2021, Atlanta Georgia.

  67. Cubeddu RJ, Murphy S, et al. Medication Use and 3-year Mortality following TAVR. Results from real-world claims data. Submitted to TCT, 2021.

  68. Makkar R., Kapadia, Chakravarty T, Cubeddu RJ et al. Outcomes of repeat transcatheter aortic valve replacement with balloon expandable sapien 3/ultra valve. Submitted to TCT, 2021.
  1. 1. Wiener P, Sarkar, Witzke C, Cubeddu RJ. Management of paravalvular leak in patient with aortic intuit valve bioprosthesis. Manuscript draft in progress.

  2. Crespo H, Carmona A, Nores M, Cubeddu RJ et al. Usefulness of Sinus of Valsalva diameters for valve size selection in patients undergoing TAVR. Manuscript Draft.

  3. Flocco G, Crespo, Cubeddu RJ et al. Implications of PFO in patient undergoing liver transplantation. Cleveland Clinic. 2018 (Work in progress)

  4. Hanna N, Carmona, Cubeddu RJ. Transseptal VSD closure in a patient with mechanical AVR and TVR. A novel approach. (Manuscript Draft)

  5. Bhansali H, Asher C, Novaro G, Herrera J, Cubeddu RJ. Echocardiographic variations of the inferior vena cava in normal subject and those with comorbid conditions. (Work in progress)

  6. Wiener P, Bhargav R. Hanna N, Cubeddu RJ, C. Witzke et al. Management of moderate to severe PVL following SAVR with Edwards intuit valve. (Work in progress)

VERIFIED PATIENT REVIEWS​

The following ratings and reviews for Robert Cubeddu are based on verified feedback collected from independently administered patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions. Patient identities are withheld to ensure confidentiality and privacy.

Loading ...